XENON PHARMACEUTICALS INC. (XENE) Shareholders’ equity 2016–2025
XENON PHARMACEUTICALS INC. (XENE) shareholders’ equity at each fiscal year-end, per SEC filings.
$581.8MFY2025 · since FY2016: $63.9M → $581.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $581.8M | -22.9% |
| FY2024 | $754.9M | -18.6% |
| FY2023 | $927.9M | +28.6% |
| FY2022 | $721.5M | +31.2% |
| FY2021 | $550.0M | +221.0% |
| FY2020 | $171.4M | +86.3% |
| FY2019 | $92.0M | — |
| FY2017 | $35.9M | -43.8% |
| FY2016 | $63.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice